IP Library Patent Application 17402426
Patent Application
App. No. 17/402,426

ENZYMES WITH RUVC DOMAINS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/402,426
Abstract

The present disclosure provides for endonuclease enzymes having distinguishing domain features, as well as methods of using such enzymes or variants thereof.

Claims (30)

1 . An engineered nuclease system, comprising:

(a) an endonuclease configured to have selectivity for a protospacer adjacent motif sequence of nnGGG (SEQ ID NO: 5517);

wherein said endonuclease comprises a RuvC_III domain,

wherein said RuvC_III domain comprises a sequence having at least 80% identity to SEQ ID NO: 2242, or a variant thereof,

wherein said endonuclease is a class 2, type II Cas endonuclease; and

(b) an engineered guide ribonucleic acid structure configured to form a complex with said endonuclease comprising:

(i) a guide ribonucleic acid sequence configured to hybridize to a target deoxyribonucleic acid sequence; and

(ii) a tracr ribonucleic acid sequence configured to bind to said endonuclease.

2 . (canceled)

3 . (canceled)

4 . The engineered nuclease system of claim 1 , wherein said endonuclease further comprises an HNH domain.

5 . The engineered nuclease system of claim 1 , wherein said tracr ribonucleic acid sequence comprises a sequence with at least 80% sequence identity to about 60 to 90 consecutive nucleotides selected from any one of SEQ ID NOs: 5476-5511 and SEQ ID NO: 5538.

6 . (canceled)

7 . The engineered nuclease system of claim 1 , wherein said engineered guide ribonucleic acid structure comprises at least two ribonucleic acid polynucleotides.

8 . The engineered nuclease system of claim 1 , wherein said engineered guide ribonucleic acid structure comprises one ribonucleic acid polynucleotide comprising said guide ribonucleic acid sequence and said tracr ribonucleic acid sequence.

9 . The engineered nuclease system of claim 1 , wherein said guide ribonucleic acid sequence is complementary to a prokaryotic, bacterial, archaeal, eukaryotic, fungal, plant, mammalian, or human genomic sequence.

10 . The engineered nuclease system of claim 1 , wherein said endonuclease comprises one or more nuclear localization sequences (NLSs) proximal to an N- or C-terminus of said endonuclease.

11 . The engineered nuclease system of claim 10 , wherein said one or more NLSs comprises a sequence selected from SEQ ID NOs: 5597-5612.

12 . The engineered nuclease system of claim 1 , further comprising a single- or double-stranded DNA repair template comprising from 5′ to 3′: a first homology arm comprising a sequence of at least 20 nucleotides 5′ to said target deoxyribonucleic acid sequence, a synthetic DNA sequence of at least 10 nucleotides, and a second homology arm comprising a sequence of at least 20 nucleotides 3′ to said target deoxyribonucleic acid sequence.

13 . The engineered nuclease system of claim 1 , wherein said engineered nuclease system further comprises a source of Mg2+.

14 . The engineered nuclease system of claim 1 , wherein said endonuclease and said tracr ribonucleic acid sequence are derived from distinct bacterial species within a same phylum.

15 . The engineered nuclease system of claim 1 , wherein said endonuclease comprises SEQ ID NOs: 421 or a variant thereof having at least 55% identity thereto.

16 . The engineered nuclease system of claim 1 , wherein said guide RNA structure comprises an RNA sequence predicted to comprise a hairpin consisting of a stem and a loop, wherein the stem comprises at least 10base-paired ribonucleotides, and an asymmetric bulge within 4 base pairs of the loop.

17 . The engineered nuclease system of claim 1 , wherein said tracr ribonucleic acid sequence of said engineered guide ribonucleic acid structure comprises a hairpin comprising at least 8base-paired ribonucleotides.

18 . The engineered nuclease system of claim 1 , wherein said guide ribonucleic acid sequence of said engineered guide ribonucleic acid structure is predicted to comprise a hairpin with an uninterrupted base-paired region comprising at least 8 nucleotides of a guide ribonucleic acid sequence and at least 8 nucleotides of a tracr ribonucleic acid sequence, and wherein said tracr ribonucleic acid sequence comprises, from 5′ to 3′, a first hairpin and a second hairpin, wherein said first hairpin has a longer stem than said second hairpin.

19 . (canceled)

20 . (canceled)

21 . (canceled)

22 . (canceled)

23 . The engineered nuclease system of claim 1 , further comprising a target DNA sequence comprising the sequence 5′-nnGGG-3′ which is 3′ to said target deoxyribonucleic acid sequence.

Assignments (6)
CHANGE OF NAME Recorded Feb 6, 2026
From: METAGENOMI, INC.
To: METAGENOMI THERAPEUTICS, INC.
Reel/Frame 073717/0149 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2025
From: CATALIO NEXUS FUND III, LP
To: AFFINI-T THERAPEUTICS, INC.
Reel/Frame 073201/0168 →
SECURITY INTEREST Recorded Mar 4, 2025
From: AFFINI-T THERAPEUTICS, INC.
To: CATALIO NEXUS FUND III, LP
Reel/Frame 070403/0862 →
MERGER Recorded Oct 13, 2022
From: METAGENOMI IP TECHNOLOGIES, LLC
To: METAGENOMI, INC.
Reel/Frame 061407/0059 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2022
From: METAGENOMI, INC.
To: METAGENOMI IP TECHNOLOGIES, LLC
Reel/Frame 061668/0098 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2022
From: THOMAS, BRIAN; BROWN, CHRISTOPHER; KANTOR, ROSE; DEVOTO, AUDRA; BUTTERFIELD, CRISTINA; ALEXANDER, LISA; GOLTSMAN, DANIELA S.A.; LIU, JASON
To: METAGENOMI, INC.
Reel/Frame 059699/0780 →